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Introduction 
Acetylcholine (ACh, Scheme 1) is an important neurotransmitter in the human 
nervous system. Acetylcholine functions as a neurotransmitter in the cholinergic 
synapses found in smooth and cardiac muscle, autonomic ganglia, and in neuromuscular 
junctions of skeletal muscle. While the storage site and release mechanism for ACh at 
the motor end-plates of skeletal muscle have been the most extensively studied, it is 
likely that the same general principles apply to cholinergic transmission at other sites. 
ACh is stored and released from motor nerve endings in quanta. 1 The ACh release 
mechanism involves a multi step process. (Fig. 1) A nerve impulse sent from the previous 
motor nerve tenninal travels through the presynaptic axon to the tenninal bulb. This 
triggers a change in the membrane potential, causing the calcium channel to open 
allowing calcil,llTl ions to migrate into the bulb. Inside the bulb are synaptic vesicles. 
Each of these vesicles containl03-IQ4 ACh molecules. The increase in calcium ion 
concentration causes these vesicles to fuse with the axonal membrane and open, releasing 
the ACh molecules into the synaptic cleft where they diffuse towards ACh receptors on 
the postsynaptic membrane. ,This triggers another nerve impulse that is passed on to the 
next motor nerve tenninaP After ACh has triggered the action potential, it must be 
rapidly hydrolyzed or the nerve will continue to send impulses and death will eventually 
result. Acetylcholinesterase (AChE, Fig. 2a), an enzyme present in the synaptic cleft, is 
responsible for hydrolyzing ACh into choline and acetate (Scheme 1). 
The mechanism by which AChE hydrolyzes ACh has been the subject of much 
debate and is still somewhat unclear. Studies of AChE using analogs of ACh and other 
compounds that inhibit the enzyme's ability to function have helped clarify some of 
these questions and have generated additional questions about the stereoselectivity of 
inhibition. Also, some of these AChE inhibitors (particularly organophosphorus 
compounds) are used in the treatment of disorders like glaucoma and 
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myasthenia gravis (a muscular debility). Use of these compounds has even been 
proposed as a possible therapeutic treatment towards the management of Alzheimer's 
disease. 3 The major drawback to the use of organophosphorus (OP) inhibitors in the 
treatment of these diseases is that OP compounds tend to be highly toxic, irreversible 
inhibitors of AChE. In order to design more effective, nontoxic AChE inhibitor that 
could better treat these disorders the stereoselectivity and mechanism of inhibition of 
AChE by OP compounds must be fully elucidated. 
Much work has been done using OP compounds to probe AChE stereoselectivity, 
active site structure, and the mechanism of hydrolysis. Work done by Wilson and his 
collaborators in the 1950's indicated that the active site of AChE is actually composed of 
an "anionic site" and an esteratic site (Fig. 3); the latter is known as the truly catalytic 
site.4 The catalytic process of AChE is pH dependent which led to the idea that the 
esteratic site contains an acidic and a basic group. This process was found to operate 
best when the acid is deprotonated and the base is protonated (the pKa of the imidazole 
base is -6.3).5 It was postulated that when ACh binds to AChE, the ester portion binds to 
the esteratic site and the quarternary amino group binds to the "anionic site." It was also 
believed that OP compounds bind to the esteratic site and, depending on the nature of 
their functional groups, the "anionic site." O'Brien studied the importance of the 
"anionic site" in ACh binding. He postulated that if binding occurred at an "anionic site" 
then it would be due mostly to coulombic interactions. He discovered that binding of an 
OP compound called amiton and several of its carbon analogs occurred through at least 
80% hydrophobic interactions (figA).4 This strongly undermined the importance and 
even the existence of an anionic site on AChE. Ordentlich, based on his research, 
postulated that a hydrophobic trimethyl binding site bound the quaternary nitrogen of 
ACh and also bound uncharged substrates and inhibitors. Further research by Ordentlich 
caused him to postulate that both an anionic and a hydrophobic site may exist as two 
partially overlapping regions.6 
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Although there is much debate regarding the anionic vs. hydrophobic sites, the 
structure of the main binding site, the esteratic site, is known more clearly. The active 
site is located at the bottom of a deep narrow gorge about 20 angstroms long. 3 (Fig. 2b, c) 
This gorge extends about halfway into the enzyme and is lined with aromatic residues. 
At the bottom of the gorge is the esteratic site. This site contains the Ser-200 residue 
and the imidazole group of histidine. 5 The serine hydroxy group acts as a nucleophile 
and attacks the sp2 carbonyl carbon of ACh forming a tetrahedral intermediate 
(Scheme 2). The imidazole group most likely serves as an acid-base catalyst by first 
deprotonating the hydroxy group during acylation of the Ser residue, then deprotonating 
water during hydrolysis of the acylenzyme, and finally reprotonating the Ser residue after 
hydrolysis. Based on the knowledge of other serine proteases, it was believed that a 
glutamate residue was present in the esteratic site to help stabilize the histidine acid-base 
catalyst through hydrogen bonding. However, work done by Daniel Quinn challenges the 
presence of the Glu residue. 5 Other amino acid residues have, through site directed 
mutagenesis, been found to play important roles in both ACh binding and stabilization of 
the tetrahedral intermediates. Work done by Ordentlich et. al. has indicated that the 
Trp-86 residue may constitute the anionic portion of the active site.6 The indole moiety 
of Trp-86 may aid in the binding of both the quarternary ammonium groups of the 
substrate and appropriate functional groups of active site inhibitors through n-cationic 
interactions'? Other studies by Sussman have shown that an oxyanion hole (Gly-121, 
122, Ala-204) and an acyl pocket (Phe-295,297; Harel et. aI., Vellom et. aI., Ordentlich 
et. al.) are also present in or near the active site. 
The composition and size of the active site gorge have also been the subject of 
much debate. AChE operates at an incredible, almost diffusion-limited, catalytic rate. It 
has a turnover number near 20,000 S-I. 8 This is an amazingly fast rate considering the 
location of the active site. The kinetics of the AChE enzyme have raised several 
questions about the movement of the AChE substrate and products to and from the active 
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site. The concept of a deep narrow gorge is not consistent with such a high turnover rate 
because ACh must diffuse into the gorge while products diffuse out. AChE possesses a 
large dipole moment which may help attract the cationic ACh dOMl the gorge towards 
the active site but which would also impede the clearance of products. 8 Site directed 
mutagenesis and molecular modeling studies have been used to explore the possibility of 
a back-door exit for the hydrolysis products, the contribution of the dipole moment to 
ACh binding and clearance of products, and the possibility that specific amino acids help 
guide ACh towards and into the active site gorge. The concept of a back door exit for the 
products of hydrolysis was proposed to explain AChE's high turnover rate.7 A 
molecular dynamics simulation conducted by Gilson in 1994 of Torpedo californica 
AChE revealed a small, thin opening of a short channel through a thin wall of the active 
site. This back door was thought to potentially function like a shutter, opening to let 
choline and acetate out and closing immediately afterward. Kronman et. at. studied the 
effects of mutagenesis on residues flanking the "back door." Several acidic residues line 
the outer opening of this cavity which would impede outward choline diffusion via an 
electrostatic field. Mutagenesis would modify this field and possibly change the turnover 
rate if choline was diffusing out of the enzyme through the back door. Their results 
suggested that choline did not exit the enzyme through the back door.7 However, new 
findings indicated that the diffusion rate of choline in product clearance is not 
electrostatic field sensitive. This suggests that product clearance from the active site 
gorge is not as difficult as was first suspected.7 
Although much research has been done on AChE hydrolysis of ACh, a large part 
of the process is still unclear. It is generally accepted that hydrolysis of ACh proceeds 
through a tetrahedral intermediate. The generally accepted mechanism for 
phosphorylation of AChE is shoMl in Scheme 3a. It has been postulated that OP 
compounds function as inhibitors of AChE because they resemble the proposed 
tetrahedral intermediate of ACh hydrolysis. However, other results refute this hypothesis 
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and instead suggest that it is actually the phosphorylated AChE enzyme that resembles 
the transition state. 9 (Scheme 3b) Still other results show that the stability of the 
complex may not always require tetrahedral geometry. For example, the trigonal 
carbamoyl-AChE complex (Fig. 5) is hydrolyzed very slowly, indicating apparent 
stability, with rates that depend on its substituents. 9 Other attempts to clarify the 
stereospecificity of AChE inhibition by OP compounds have yielded interesting but 
somewhat contradictory results. It has been shown that stereoisomers of certain nerve 
agents have different inhibitory potencies. to For example, (-)sarin is a much more potent 
AChE inhibitor (AChE obtained from bovine erythrocytes) than (+)sarin.(Fig. 6) Upon 
development of better isolation techniques, it was discovered that the P(-) isomers of 
both sarin and soman had inhibitory rates 3-4 orders of magnitude higher than those of 
the P(+) isomers. lO A model of the AChE active site was developed by Jarv to explain 
this stereospecificity. I] (Scheme 4) Jarv' s model contains, in addition to His and Ser, 
two hydrophobic groups for binding of the OR"and R groups as well as a third 
hydrophobic region, P3' for binding of the leaving group X. Structure-activity 
relationship studies indicated that the size of the P2 pocket can only accommodate acetyl 
groups while PI can bind butoxy groups. According to Jarv, during OP inhibition of 
AChE the leaving group X occupies the axial position of the trigonal bypyramidal 
transition state and is bound by the P3 subsites. The serine hydroxy group attacks at the 
axial face of the phosphorus atom opposite X. The phosphoryl oxygen has its position 
fixed by hydrogen bonding. The R and OR' groups should occupy the PI and P2 subsites. 
This explains the preferential binding of one enantiomer over the other when R and OR' 
differ considerably in size. In the case of sarin and soman (Fig.6) the groups 
corresponding to Rand R' in Jarv's mechanism are considerably different in size. The 
binding of AChE by taran and VX (other nerve agents, Fig.6) is less stereospecific. The 
explanation is straightforward: the groups corresponding to the Rand R' groups in Jarv's 
mechanism are more similar in size. 10 Other studies using these compounds have shown 
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that conflicting data may be obtained regarding which stereoisomer is a more potent 
inhibitor if AChE is obtained from different sources. 
After examining some of the literature regarding studies of AChE inhibition and 
ACh hydrolysis, it is clearly apparent to me that many of the theories on the mechanism 
of ACh hydrolysis are still not totally defined. Also, the mechanism and stereoselectivity 
of AChE inhibition are still quite ambiguous. Therefore, additional work needs to be 
done with new inhibitors to ascertain the correct information regarding both the 
stereospecificity and mechanism of the mode of action of the AChE enzyme. 
We propose the total synthesis of a conformationally constrained 
organophosphorus analog of acetylcholine (5., Scheme 5). This compound will contain 
two crural centers, one being the phosphorus atom and the other being the pyrrolidine 
ring carbon ~ to the phosphorus atom. The chiral ~ carbon is conformationally 
constrained because it is part of the pyrrolidine ring. Studies with such a compound 
should allow us to make substantial progress towards the clarification ofthe 
stereospecificity of AChE inhibition by OP compounds and eventually help us understand 
more about the structure ofthe AChE active site. The synthesis begins with 
Cbz-L-proline methyl ester (1) which is commercially'available. Reduction of the methyl 
ester with sodium borohydride in the presence of CaCl2 will yield Cbz-L-prolinol (2). 
Phosphorylation of the primary alcohol will yield a pair ofdiastereomers (3,.). After 
separation by flash chromatography, each diastereomer will be subjected to 
hydrogenolysis, to cleave the Cbz-protecting group, followed by methylation of the amine 
with methyl iodide. By repitition of this process with Cbz-D-proline methyl ester, we 
should be able to access all four stereoisomers. 
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Results and Discussion 
The first step ofthe synthesis was to prepare a large amount (4-5g) of 
Cbz-prolinol GD by reduction of Cbz-proline methyl ester (1). Previous work on this 
project had shown that sodium borohydride was not a strong enough reducing agent. 12 A 
literature procedure indicated that methyl esters could be reduced with calcium 
borohydride generated in situ with sodium borohydride and calcium chloride. 13 
Cbz-prolinol was synthesized in 83% yield using this procedure. The 1H spectrum of the 
pure product was identical to a IH spectrum ofCbz-prolinol prepared and purified by 
Darshan Mehta, a former member of Dr. Frick's group, during work on this project in 
1996. 
Previous work by Darshan Mehta, Sulay Jhaveri, and Jay-James R Miller on the 
synthesis of this organophosphorus analog of acetylcholine (2) has indicated that the 
troublesome step is the phosphorylation of Cbz-prolinol; therefore, much of our work 
focused on this step (Scheme 6). The first phosphorylating agent we attempted to 
synthesize was N, N,- diisopropylaminomethylchlorophosphine (6., Table 1). A literature 
procedure indicated that this reagent had been used to phosphorylate a secondary 
alcohol. 14 Although we were working with a primary alcohol the procedure for preparing 
this phosphorylating reagent was not complex so we attempted to phosphorylate our 
alcohol with it. Following a literature procedure for preparation of this reagent, we 
attempted a simple displacement of one of the chlorine atoms on 
dichloromethylphosphine with N,N,- diisopropylamine. 15 However, the IH spectrum of 
the product did not show the peaks expected to be present upon introduction of a 
diisopropylamino group. Communicating with the author of the paper on this synthesis 
yielded no additional information. This synthesis was attempted again but the 1H 
spectrum looked quite similar to the first attempt. The IH spectrum of this compound 
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did not indicate whether or not the desired product had been synthesized; therefore, 
phosphorylation was attempted with this product. The 1H of the crude product of this 
reaction did not contain the doublet expected from coupling of the methyl protons with 
phosphorus. It was concluded that this method of phosphorylation was unsuccessful. 
However, after further analysis of the IH spectrum of 
N, N,-diisopropylaminomethylchlorophosphine it was determined that N, 
N,-diisopropylamine was quite concentrated in the reaction mixture and may have 
masked our product. Based on these results, this synthesis and phosphorylation will be 
attempted again in the future. 
Phosphorylation of Cbz-prolinol was also attempted with methylphosphonic 
dichloride (1, Table 1). Previous work had shown this method to be potentially 
successful but not a very attractive method because the product reacts with silica gel and 
is therefore difficult to purify. However, it was attempted because other methods to 
purify compounds sensitive to silica gel exist e.g.. , alumina, fluorisil. Also, methods 
exist that would allow the phosphoryl oxygen to be converted to sulfur which might 
make the compound easier to purify. The reaction was run in dichloromethane or 
benzene using IH-tetrazole as a catalyst. According to the literature, IH-tetrazole 
enhances both the reactivity of phosphonic dichlorides and the selective displacement of 
a single chlorine from phosphonic dichlorides. 16 TLC analysis of both reactions showed 
that all of the prolinol was consumed but only baseline material was present on the plate 
in the product lane. The product of this reaction should have a greater Rf value than 
prolinol because it no longer contains an alcoholic proton. The 1H spectrum of each 
crude product showed doublets that may have been from coupling of the methoxy and 
methyl protons with phosphorus at 8 1.4-1. 5 ppm; however, the doublets were only 
separated by about 0.5 ppm. If these doublets corresponded to the methyl and methoxy 
protons we would have expected the methoxy doublet to be further downfield (more than 
0.5 ppm) than the methyl doublet. The IH spectrum of the crude products also indicated 
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that the Cbz protecting group might have been cleaved. Another phosphorylation was 
attempted with this reagent in THF using triethylamine as a base instead because we 
suspected the Cbz group may have been cleaved by acid. In organic solvents 
triethylamine is a stronger base than N,N-diisopropylamine and might prevent Cbz 
cleavage. TLC analysis of the reaction showed all starting material was consumed; 
however, only baseline material was present in the product. The 1H spectrum of the 
crude product showed that the Cbz group had not been cleaved but did not show the 
expected doublets for methoxy or methyl proton coupling with phosphorus. 
Phosphorylation using methylphosphonic dicWoride was also attempted in toluene. A 
slightly modified procedure was used in which the prolinol was added to the reaction 
mixture last. The Cbz group was not cleaved but other than that, this technique provided 
results no different than previous attempts with this phosphorylating reagent. The IH 
spectrum did not show the expected doublets. 
We also attempted to phosphorylate Cbz-prolinol with thiophosphorylcWoride (.8., 
Table 1). A previous paper on this project had indicated that, using this reagent, 
Cbz-prolinol may have been successfully phosphorylated but the product was quite 
impure and an attempt at purification had not been successful. 17 The reaction was run in 
both dichloromethane and THF with triethylamine as a base. TLC analysis showed two 
spots with Rr values greater than prolinol. This was not expected because the phosphorus 
atom is not chiral so diastereomers should not have been present. The product of the 
THF reaction was isolated as the dichloride and purified by chromatography. The 1H 
spectrum of the crude product and of the pure product were suprisingly different but 
neither appeared to verify that the desired product had been synthesized. Methanol and 
triethylamine were added to the reaction run in dicWoromethane, and the product was 
then isolated as the monomethoxylated chloride compound. The 1H spectrum (11) of the 
crude product did not show the expected doublet for methoxy proton coupling with 
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phosphorus (only one doublet was expected because this phosphorylating reagent did not 
contain a methyl group). 
A literature search yielded a new and promising phosphorylating reagent 
--methylphosphonothioic dichloride (2., Table I). This compound had several advantages 
over compounds used previously: I) it was a more mild phosphorylating reagent, 2) the 
product would probably be easier to purify because it would contain sulfur, not oxygen. 
This phosphorylating reagent had one disadvantage: it was not commercially available. 
However, methylphosphonothioic dichloride was successful prepared according to a 
literature procedure. IS The first attempt of the synthesis of methylphosphonothioic 
dichloride was successful. This was verified by IH NMR. The literature SpeCtrum 19 for 
the starting material, dichloromethylphosphine, contained a doublet at around 82.2 ppm 
which corresponded to the methyl protons coupling with phosphorus. Upon addition of 
sulfur, a moderately electronegative atom, we would expect the methyl protons to be 
more deshielded and therefore their signal should shift downfield. This was the case as 
the IH spectrum of the product showed one doublet at around 8 2.8 ppm corresponding ,to 
the methyl protons. The BC spectrum of the phosphine contained one doublet at about 8 
30 ppm. Again we expected this signal to shift downfield in the product for the same 
reason as we expected the methyl proton signal to shift downfield, which it did, having a 
value of839.6 ppm. The 31p NMR spectrum of the product showed one phosphorus 
environment which was expected because the phosphorus atom was achiral. The mass 
spectrum of the product showed the molecular weight of 148 g/mol. In addition to this 
peak, fragmentation of both chlorine atoms yielded peaks at 113 and 77 with the 
appropriate M + 2 and M + 4 peaks corresponding to 37CI isotopes. However, the yield 
after short path distillation was extremely low (30 mg, 0.47%). This synthesis was 
attempted again and the desired product was obtained after distillation in 62% yield (3.93 
g). It was determined that the pressure and temperature must be carefully controlled 
during distillation (see experimental section for details). 
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Phosphorylation of Cbz-prolinol with methylphosphonothioic dicWoride was 
attempted using a literature procedure. 2o The reaction was run in dichloromethane with 
pyridine as a base. The IH spectrum of the crude product contained two doublets at 
about 8 1.75 ppm (methyl group) and 8 3.70 ppm (methoxy group). However, after 
purification by flash chromatography neither of the doublets were present and the 
spectrum in general did not look similar to the spectrum ofthe crude product. It was 
concluded that the compound may have decomposed on the silica gel during 
purification. We attempted this phosphorylation again and hoped to purify the product 
using fluorisil or alumina but analysis of the product, prior to purification, by mass 
spectrometry (312 g/mol) showed that the reaction did not yield the desired product. 
Phosphorylation with this reagent in toluene was also attempted with triethylamine as a 
base. A slightly modified procedure was followed in which the Cbz-prolinol was added 
to the reaction last. The mass spectrum of the crude product did not contain the expected 
molecular weight peak (312 g/mol). 
An attempt was made to displace both chloride groups of the 
methylphosphonothioic dichloride compound with methoxy groups. The 
phosphorylating agent was stirred in dichloromethane in the presence of an excess of 
methanol with pyridine as a base. Characterization of the dimethoxylated compound by 
1H NMR would give an indication as to where the methoxy protons would show up in the 
phosphorylation product spectra; however, the mass spectrum of this product did not 
contain the desired molecular weight peak of 140 g/mol, so no further characterization 
was performed. 
Phosphorylation of benzyl alcohol with methylphosphonothioic dichloride was 
attempted to see if this reagent could phosphorylate a different primary alcohol. The 
reactions were both run in dicWoromethane with pyridine as a base in one and 
triethylamine as a base in the other. No methanol was added to displace the remaining 
chloride with a methoxy group. Neither reaction yielded the desired product. This was 
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verified by their mass spectra--neither contained the molecular weight peak of225.05. It 
was suspected that a substitution reaction may have taken place at the benzylic carbon. 
Benzylic carbocations are resonance stabilized and methylchlorothiophosphonate is a 
good leaving group. These conditions would support nucleophilic substitution of by 
chloride ion at the benzylic carbon. The mass spectra of both reactions contained the 
appropriate peak for the molecular weight of benzyl chloride (126 glmol), but they also 
contained many other peaks. Therefore, benzyl chloride was probably not the only 
product of the reaction but no further characterization of undesired products was 
attempted. 
To ensure that methylphosphonothioic dichloride was not simply decomposing 
under the reaction conditions, it was stirred with pyridine in dichloromethane. The 
molecular weight peak of the sulfur reagent was present at 148 glmol. 
Further attempts to phosphorylate Cbz-prolinol with the monomethoxylated 
methylphosphonothioic dichloride and methylphosphonic dichloride compounds were 
unsuccessful. The monomethoxylated reagents were prepared in situ by addition of 
methanol in THF with triethylamine as a base. Triethylamine and prolinol were then 
added. The IH spectra of the crude products did not contain the expected methoxy and 
methyl doublets. This method was attempted again with only the sulfur reagent. 
Methoxylation was attempted with both methanol and sodium methoxide and completion 
of this reaction was verified by mass spectrometry. The molecular weight of the 
methoxylated compound was present (144 glmol) in the spectra of both products .and 
neither spectra contained a peak at 148 corresponding to the starting material. Addition 
ofCbz-prolinol to the monomethoxylated product obtained using methanol did not yield 
the desired product. Neither of the expected doublets were present in the 1H spectrum. 
However, doublets around 82.0 and 3.5 ppm were observed in the spectrum ofthe 
product obtained by phosphorylation with the phosphorylating reagent generated via 
sodium methoxide. The 31p spectrum of this product showed that several phosphorus 
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made. The 31p spectrum of the starting material showed one enviromnent as expected. 
Therefore, it was concluded that the desired product was not obtained and the problem 
did not result from the starting material. Characterization of methylphosphonic 
dichloride by 1H NMR showed one doublet indicating that this starting material was also 
sound and pure. 
After several unsuccessful attempts at phosphorylating Cbz-prolinol with various 
reagents (Table 1), one is inclined to think that there is something fundamentally wrong 
with the reaction arising from the molecule we are trying to phosphorylate. Reactions 
described herein using these phosphorylating reagents to phosphorylate other alcohols are 
published in the literature. We have postulated that the Cbz protecting group may be 
causing an unwanted cyclization reaction with the alcohol oxygen once it is 
phosphorylated (Fig. 7). This has caused us concern as to the use of the Cbz protecting 
group. 
Future work on this project will include the use of different non-earbamate 
protecting groups and different phosphorylating reagents. We are currently working on,a 
new method to prepare the monomethoxylated phosphorylating reagent (ll, Scheme 7).21 
This procedure began with dimethyl methylphosphonate (ll), which was then converted 
to the phosphonic acid 
(ll) using t-butylamine and Dowex H+. The acid converted to the chloridate (11) with 
oxalylchloride. The chloridate was immediately reacted with Cbz-prolinol in 
dichloromethane and N,N,-dimethylaminopyridine with triethylamine as a base. Analysis 
of the crude product by mass spectrometry indicated that the desired product was not 
obtained (295 g/mol)~ however, a peak was present at 127 which corresponds to the 
weight of the cyclization product (lA, Fig. 7) mentioned above. This is strong 
preliminary evidence that the Cbz protecting group is the primary problem with this 
synthesis. Additional analysis of the product by NMR will be conducted to try and verify 
the structure of this product. If we are successful in identifying this product then the 
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verify the structure of this product. If we are successful in identifying this product then 
the total synthesis of our analog (2) will be reattempted using a Boc protecting group, 
which is not susceptible to chloride attack, on the Cbz-L-prolinol nitrogen. 
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Experimental 
General Procedures 
Dichloromethylphosphine, methylphosphonic dichloride, IH-tetrazole, 
phosphorylchloride, and dimethyl methylphosphonate were all purchased from Aldrich. 
All reactions were run under a nitrogen atmosphere. Dichloromethane, t-butylamine, and 
toluene were distilled from CaH2. Pyridine was refluxed over NaOH for 0.5 h and then 
distilled from NaOH. TIIF was distilled from sodium benzophenone until the still went 
dry. Then it was obtained from Aldrich. Anhyrous ether was obtained from Fischer 
Scientific. TLC analyses were carried out using 1: 1 ethyl acetatelhexanes as the eluent. 
All TLC analyses were performed with UV light and 2,6-dibromoquinone-4-chloroimide 
as a stain (purchased from Lancaster) with the exception of the synthesis of Cbz-prolinol. 
This was analyzed only by UV light. Column chromatography experiments were 
performed on silica gel with various ratios of ethyl acetatelhexanes as the eluents. IH 
and 13C NMR spectra were obtained on a JEOL NMR spectrometer in CDCl3 unless 
otherwise specified. IH NMR spectra were obtained at 270 MHz with delta values 
relative to TMS (0 ppm). 13C spectra were obtained at 63.5 MHz with delta values 
relative to the CDCl3 triplet (77 ppm). All mass spectra were obtained on an Hewlet 
Packard HP 6890 GC-MS system in dichloromethane, methanol, or CDCl3 at an oven 
temperature of 150 °C. 
Synthesis ofdiisopropylaminochloromethylphosphine (Scheme 8;.6., Table 1): A 500 mL 
flask was charged with anhydrous diethyl ether (100 mL). Dichloromethylphosphine (5.0 
g, 42.8 mmol) was added and the mixture was cooled while stirring in an ice bath. 
Diisopropylamine (11.99 mL, 85.6 mmol) was added dropwise. The mixture was stirred 
17
 
· for 1h and then vacuwn filtered. The solvent was removed by rotary evaporation. 
Analysis by IH NMR showed that the desired product was not obtained 
Synthesis oJCbz-L-prolinol (2, Scheme 5): A 100 mL round bottom flask was charged 
with Cbz-L-proline methyl ester (5.10 g, 19.4 rnmol), ethanol (40 mL), TI-IF (20 mL) and 
CaCI2 (4.32 g, 38.9 rnmol). The mixture was cooled in an ice bath and NaBH4 (2.97 g, 
78.5 mmol) was added portionwise. The mixture was allowed to stir overnight and come 
to room temperature, then quenched with 10% citric acid (-90mL). The mixture was 
then diluted with ethyl acetate (200 mL) and the layers were separated. The aqueous 
layer was extracted with ethyl acetate. The organic layers were combined and washed 
with citric acid, saturated NaCl, and dried over anhydrous sodium sulfate. The solvent 
was removed by rotary evaporation to yield a viscous oil which was purified by flash 
chromatography using 1: 1 EtOAclHex as the eluent. Purification yielded 4.02 g (84% 
yield) of pure product. IH NMR: 8 1.55-2.44 (m, 4H), 3.33-3.67 (m, 4H), 3.92-4.00 (m, 
1H), 5.12 (s, 2H), 7.26-7.35 (m, 5H). BC NMR: 824.00,28.58,47.70,60.72,67.19, 
127.88, 128.02, 128.47, 136.53, 157.08. 
Phosphorylation oJCbz-L-prolinol (2" Scheme 5) with methylphosphonic dichloride (1. 
Table 1): A 25 mL flask was charged with 1H-tetrazole (4 mg, 0.057 mmol), 
methylphosphonic dichloride (60 mg, 0.45 mmol), dichloromethane (6.5 mL), and 
diisopropylethylamine (0.25 mL, 1.44 mmol). The mixture was cooled in an ice bath and 
Cbz-L-prolinol (100 mg, 0.49 mmol), dissolved in dichloromethane (2 mL), was added 
dropwise. The reaction was stirred overnight and allowed to come to room temperature. 
Reaction progress was monitored by TLC. Methanol (10 mL) was added, the mixture 
was stirred for 15 min, and then vacuum filtered. The solvent was removed by rotary. 
Analysis of the product by IH NMR indicated that the desired product was not obtained. 
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Phosphorylation ofCbz-L-prolinoi (2) with diisopropylaminochloromethylphosphine (6.., 
Table 1): L-prolinol (100 mg, 0.49 mmol) and diisopropylethylamine (0.25 g, 1.95 
mmol) were dissolved in toluene (5 rnL), and the mixture was cooled in an ice bath. 
Diisopropylaminochloromethylphosphine (90 mg, 0.50 mmol) was added, and the 
reaction was stirred for 24h. An additional 45 mg (0.25 mmol) ofthe phosphine was 
added after TLC showed that the reaction had not gone to completion. The reaction was 
stirred for an additional 60 h but was still not complete as indicated by TLC analysis. 
The mixture was diluted with ethyl acetate, washed twice with 10% sodium bicarbonate, 
dried over sodium sulfate, and the solvent was removed by rotary evaporation. Analysis 
ofthe product by IH NMR indicated that the product was not the desired one. 
Synthesis ofmethylphosphonothioic dichloride (Scheme 9; 2., Table 1): A 10 rnL 
round-bottom flask was flame-dried and charged with aluminum chloride (342 mg, 2.6 
mmol) and dichloromethylphosphine (5 g, 42.76 mmol). The mixture was cooled to -78 
°C, and sulfur (1.36 g, 42.4 mmol) was added portionwise. The mixture was stirred for 
~60 h and allowed to rise to room temperature. The mixture was distilled at 9 mmHg and 
44 °C, and the product was analyzed by IH NMR, 13CNMR, 31p NMR, and mass 
spectrometry. IH NMR 02.2 ppm (d, 3H), 13CNMR: 039.6 ppm (d), 31p NMR: 080 
ppm, GC/MS: 148, (150 and 152 for M+2 and M+4), 113 (115 for M+2), 77. 
Phosphorylation ofCbz-L-prolinol (2) with thiophosphoryl chloride (.8., Table 1): A 25 
rnL flask was charged with Cbz-L-prolinol (133 mg, 0.65 mmol), triethylamine (0.20 rnL, 
1.44 mmol), THF (10 rnL) and then cooled in an ice bath. Thiophosphoryl chloride (117 
mg, 0.69 mmol) was added dropwise and the reaction was stirred overnight and allowed 
to come to room temperature. TLC analysis indicated that the prolinol had been 
consumed. The reaction mixture was filtered through celite, the solvent was removed by 
rotary evaporation, and the product was purified by flash chromatography using 20% 
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ethyl acetate in hexanes as the eluent. Analysis by IH NMR indicated that the desired
 
product had not been obtained.
 
Phosphorylation ojCbz-L-prolinoi (2.) with methylphosphonothioic dichloride (2., Table
 
1): A 25 mL flask was flame dried and charged with Cbz-L-prolinol (155 mg, 0.763
 
mmol), dichloromethane (8 rnL), and pyridine (0.25 mL, 3.1 mmol), and cooled to 0 °C.
 
Methylphosphonothioic dichloride (347 mg, 2.33 mmol) was added dropwise and the
 
reaction was allowed to stir overnight while coming to room temperature. The reaction
 
mixture was cooled to 0 °C. Pyridine (1.75 mL, 21 mmol) and methanol (0.2 mL, 4.93
 
mmol) were added. The reaction was stirred for 24 h and allowed to come to room
 
temperature. The reaction mixture was diluted with ethyl acetate, and washed with
 
saturated ammonium chloride and water. The aqueous layers were combined and back
 
extracted with ethyl acetate. The organic layers were combined, washed with saturated
 
sodium chloride, and dried over sodium sulfate. The solvent was removed by rotary
 
evaporation and high vacuum yielding 240mg of crude product. The product was
 
purified by silica gel flash chromatography using 20% ethyl acetate in hexanes as the
 
eluent. Analysis of the product by IH NMR showed that the desired product had not been
 
obtained.
 
Dimethoxylation ojmethylphosphonothioic dichloride (Scheme 10):
 
A solution of methylphosphonothioic dichloride (30 mg, 0.2 mmol), pyridine (0.5 mL,
 
6.2 mmol), and dichloromethane (3 mL) was cooled in an ice bath and methanol (1 mL, 
24.7 mmol) was added. The reaction was stirred overnight and allowed to rise to room 
temperature. The reaction was filtered, the solvent was removed by rotary evaporation. 
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·	 Analysis by gas chromatography/mass spectrometry did not show the desired molecular 
weight peak (140.92 g/mol). 
Phosphorylation ofbenzyl alcohol (Scheme 11) with methylphosphonothioic dichloride: 
A flask was flame-dried and charged with benzyl alcohol (63 mg, 0.58 mmol), 
triethylamine (219 mg, 2.16 mmol), and dichloromethane (2 mL). The mixture was 
cooled in an ice bath and methylphosphonothioic dichloride (280 mg, 1.88 mmol) was 
added. The reaction was stirred for 60 h and allowed to come to room temperature. TLC 
analysis indicated that the benzyl alcohol had been consumed. Ether (15 mL) was added 
and the reaction was filtered twice through celite. The solvent was removed by rotary 
evaporation. Analysis by gas-chromatography/mass spectrometry indicated that the 
desired product had not been obtained (225 g/mol). 
Decomposition test ofmethylphosphonothioic dichloride: 
A flame-dried flask was charged with a few drops of methylphosphonothioic dichloride. 
A few drops of pyridine and a few milliliters ofdichloromethane were added, and the 
reaction was stirred overnight, and the solvent was removed by rotary evaporation. 
Analysis by gas-chromatography/mass spectrometry indicated no decomposition had 
occurred. 
Phosphorylation ofCbz-prolinol (2) with methylphosphonothioic dichloride (2.) 
(procedure 2): 
A flame-dried flask was charged with methylphosphonothioic dichloride (155 mg, 1.04 
mmol), toluene (5 mL), and triethylamine (203 mg, 2.0 mmol). Cbz-prolinol (205 mg, 
1.01 mmol) was dissolved in toluene (2 mL) and added dropwise to the reaction mixture. 
Analysis by TLC indicated that the prolinol had been consumed. Methanol (32.4 mg, 
1.01 mmol) was added dropwise to the reaction mixture and the mixture was stirred over 
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the weekend. After analysis byTLC, the mixture was diluted with ether (10 mL), and 
then filtered through celite. The solvent was removed by rotary evaporation and the 
product was analyzed by mass spectrometry. 
Phosphorylation ojCbz-prolinol (2) with methylphosphonic dichloride (2) (procedure 2): 
A flame-dried flask was charged with methylphosphonic dichloride (106 mg, 0.78 
mmol), toluene (5 mL), lH-tetrazole (catalytic amount), and triethylamine (180 mg, 1.78 
mmol). Cbz-prolinol (169 mg, 0.831 mmol) dissolved in toluene (2 mL) was added 
dropwise, and the mixture was stirred overnight. The reaction was analyzedby TLC and 
ether was added. The mixture was filtered through celite, and the solvent was removed 
by rotary evaporation and vacuum pumping. The product was analyzed by FT-IR and IH 
NMR spectroscopy and then redissolved in toluene (7 mL) and triethylamine (0.25 mL, 
1.78 mmol). Methanol (51 ~L, 1.25 mmol) was added, and the mixture was stirred 
overnight. Ether was added, the mixture was filtered through celite, and the solvent was 
removed by rotary evaporation and high vacuum. Analysis by IH NMR indicated that t~e 
desired product had not been obtained. 
Phosphorylation ojCbz-prolinol (2) with monomethoxylated methylphosphonic 
dichloride (ll, Table 1): 
A flame-dried flask was charged with methylphosphonic dichloride (139 mg, 1.05 
mmol), THF (4 mL), and Et3N (160 mg, 1.58 mmol). Methanol (33.6 mg, 1.05 mmol) 
was added and the reaction was stirred for 4h. Et3N (0.15 mL, 1.05 mmol) was added 
followed by addition of Cbz-prolinol (244 mg, 1.20 mmol) in THF (3 mL). The reaction 
was stirred overnight, analyzed by TLC, filtered through celite, and the solvent was 
removed by rotary evaporation. Analysis by IH NMR indicated that the desired product 
had not been obtained. 
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Phosphorylation oJCbz-prolinol (2) with monomethoxylated methylphosphonothioic 
dichloride (ill, Table 1): 
A flame-dried flask was charged with TIIF (4 mL), methylphosphonothioic dichloride 
(l08 mg, 0.725 mmol), and E~N (l09 mg, 1.05 nunol). Methanol (23.7 mg, 0.741 
nunol) was added and the reaction was stirred for 3.5 h. An aliquot was removed and 
analyzed by mass spectrometry. Et3N (0.15 mL, 1.08 nunol was added followed by 
addition ofCbz-prolinol (148 mg, 0.728 nunol). The reaction was stirred overnight, 
filtered through celite, and the solvent was removed by rotary evaporation and high 
vacuum. Analysis by IH NMR indicated that the desired product had not been obtained. 
Phosphorylation oJCbz-prolinol (2) with monomethoxylated methylphosphonothioic 
dichloride (lQ.) (procedure 2): 
A flame-dried flask was charged with sodium methoxide (57 mg, 1.05 mmol), and TIIF 
(8 mL). Methylphosphonothioic dichloride (164 mg, 1.10 mmol) was added and the 
mixture was stirred for 3.5 h. An aliquot was removed and analyzed by mass 
spectrometry. This analysis indicated that the reaction had not gone to completion. 
Sodium methoxide (85 mg, 1.57 nunol), E~N (0.47 mL, 3.34 nunol), and methanol (33.9 
j.l.L, 0.84 mmol) were added. The reaction was stirred for 5 h followed by addition of 
Cbz-prolinol (340 mg, 1.67 nunol). An additional 5 mL ofTHF was added. The reaction 
was stirred overnight, filtered through celite, and the solvent was removed by rotary 
evaporation and high vacuum. Analysis of the product by IH NMR and 31p NMR 
indicated that the desired product had not been obtained. 
Synthesis ojmethoxymethylphosphonic acid (U Scheme 7): 
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A flame-dried flask was charged with dimethyl methylphosphonate (5.13 mL, 47.31 
mmol) and tert-butylamine (130 mL, 1.24 mol). The mixture was refluxed for 24 h. An 
aliquot was remove, diluted with ethyl acetate (2 mL), extracted with citric acid (1 mL), 
and the organic layer was analyzed by gas-chromatograpy/mass spectrometry. The 
reaction mixture was refluxed for 24 h and then analyzed by GCIMS again using the 
same citric acid extraction procedure. The mixture was refluxed for an additional 60 h, 
and the solvent was removed by rotary evaporation. Methanol (170 mL) and Dowex H+ 
(68 g) were added. The mixture was stirred for 45 minutes, vacuum filtered, and the 
solvent was removed by rotary evaporation yielding 7.5 g ofthe acid. Analysis of the 
product by GCIMS indicated that the desired product had been obtained (111 g/mol). 
Synthesis ofmethoxymethylphosphonochloridate (ill Scheme 7): 
A flame-dried flask was charged with methoxymethylphosphonic acid (636 mg, 5.78 
mmol) and dichloromethane (25 mL). The mixture was cooled to 0 °c and oxalyl 
chloride (841 mg, 6.62 mmol) was added dropwise. The reaction was stirred for 6 h, an 
aliquot was analyzed by GeIMS, and the solvent was removed by rotary evaporation and 
high vacuum yielding 146 mg of the choridate. The choridate was immediately reacted 
with Cbz-L-prolinol. 
Phosphorylation ofCbz-L-prolinol CD with methoxymethylphosphonochloridate (10): 
A flame-dried flask was charged with methoxymethylphosphonochloridate (146 mg, 1. 14 
mmol), dichloromethane (20 mL), N, N, 4-dimethylaminopyridine (7 mg, 0.057 mmol) in 
dichloromethane (2 mL), and Et3N (290 mg, 2.87 mmol). Cbz-L-prolinol (202 mg, 0.99 
mmol) was dissolved in dichloromethane (3 mL) and added to the reaction mixture. 
After analysis by TLC the mixture was concentrated in vacuo, diluted with ethyl acetate 
. . 
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(20 mL), and filtered through celite. The mixture was washed with saturated sodiwn 
bicarbonate, water, and dried over sodium sulfate. The solvent was removed by rotary 
evaporation to yield 200 mg of crude product. Analysis of the product by lH NMR, l3C 
NMR, and GeIMS indicated that the desired product was not obtained. 
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Appendix I: Figures, Scbemes, and Tables 
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Scheme 1
 
The Hydrolysis of Acetylcholine
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cleft 
This is a figure of a cholinergic motor nerve terminal showing the acetylcholine reI ase 
mechanism. The little gre n spheres are acetylcholine molecule . The red spheres that 
the acetylcholine molecules bind to are acetylcholine receptors. 
Ref. Biology, ampbell, N.A., Benjamin/Cummings PUblishing Co.: 1993. 
The 3-D structure of Torpedo cali/arnica acetylcholinesterase looking down the gorge. 
The gorge is lined with several aromatic residues. 
Ref. http://www.weizmann.ac.iJrcskurt/fig3 .html 
Once inside the enzyme the acetylcholine molecule is positioned by several amino acid 
side chains. Serine and histidine side chains (lower right) prepare to catalytically 
hydrolyze acetylcholine into choline and acetate. 
Ref. http://www.tc.comell.edu/er/sci93/dis28ache/dis28d.html 
Ref. http://www.ccd.bnl.gov/visualization/gallery/pdb/images/acLdet.gif 
Figure 3 
AChE Active Site 
hydrophobic 
subsite 
hydrophobic 
subsite 
anionic subsite histidine 
serine residue residue 
esteratic subsite 
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Ref. O'Brien, R.D., Phosphorylation and Carbamylation of Cholinesterase, Annals New York 
Academy of Sciences, 204-214 
Scheme 2 
Mechanism of ACh Hydrolysis 
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Mechanism of Phosphorylation
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imidazole 
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This scheme shows the resemblance of the phosphoryl enzyme to the acylation transition 
state for ACh hydrolysis. Both the phosphoryl enzyme and the acylation transition state 
have tetrahedral geometries. It is postulated that OP compounds are potent AChE 
inhibitors because they mimic the geometry of the acylation transition state. 
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(TS-DP) 
Ref. Chemical Approaches to Understanding Enzyme Catalysis: Biomimetic Chemistry 
and Transition State Analogs, Ashani, Y.,Green, B.S., Elsevier Scientific 
Publishing Co.: Amsterdam, 1981, Vol. 10. 
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Structures of Nerve Agents
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Scheme 4
 
Jarvis Proposed Mechanism of Phosphorylation
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Scheme 5 
Proposed Synthesis of The ACh Analog 
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Table 1 
Summary of Phosphorylating Reagents 
and Reaction Conditions 
Compound # Q z a .a 1Q 11 
N(CH(Mebb 0 S S S 0 II II II II III p. P. P. P. P. 
P, /1' C,/I'CI /1' /1' /1' CI/ Me CI CI Me CI CI CI Me MeO CIMe MeO CIMe 
1H-tetrazole, CH2CI2 , Undesired (i-PrhNEt Product 
H-tetrazole, Benzene, Undesired 
(i-PrhNEt Product 
THF, (i-PrhNEt Undesired 
Product* 
1H-tetrazole, THF, Et3N Undesired 
Product 
THF, Et3N Undesired Undesired Undesired Product* Product" l Product 
CH2CI2 , Et3N Undesired Undesired 
Product Product* 
CH2CI2 , Pyridine Desired 
Prod., dec. 
on column** 
Toluene, Et3N Undesired Undesired 
Product Product 
1 
* Product isolated as the chloride prior to addition of MeOH. **Rxn was attempted again but was
 
unsuccessful. 
III
Methoxy product was obtained using sodium methoxide in one reaction.
 
Figure 7 
Possible Cyclization Reaction After Phosphorylation 
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Scheme 8 
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Ref. Agrawal, S., and Goodchild, J., Tet. Lett., 1987,28,3539-3542 
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Ref. Wolfgang, K.D., Brill, W.K.D., Caruthers, M.H., Tet. Lett, 1987, 28, 3205-3208 
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Appendix II: Spectral Data 
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Spec Type • DELTAc.-NMIl
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Data Format • 1D COMPLEX 
Dimensions • X 
Dim Title • 1H 
Dim Siz. • 16384 
Dim units • [ppm] 
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X_domain • 1H 
X_offs.t • 5.0[ppm] 
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Spec Sit. • Zclip•• 270 
0 Spec '1'ype • DZL'l'A_NMRg 
Data Pormat • 1D COMPLEX 
Dimen.ion. • X 
Dim '1'itl. • 1H 
0 Dim Size • 1638'g Dim Unit. • [ppm] 
Scan. • 16 
X_domain • 1R 
X_off••t • 5.0[ppm] 
0 X_freq • 270.167'3928[KRz]c:i 
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File C:\HPCHEM\1\DATA\DJMl-27.D 
Operator D. Megott 
Acquired 14 Jan 98 2:49 pm using AcqMethod DEFAULT 
Instrument GC/MS Ins 
Sample Name: Phosphine + Sulfur 
Misc Info 
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Spec Site • Eclipse 270 
Spec Type • DELTA_NMR 
Data Format • lD COMPLEX 
Dimensions 
• XDim Title 
• 1H 
Dim Size • 16384 
Dim units • [ppmJ
Scans • 16 
X_domain 
• lH 
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Spin--l1et • 16[HzJ
Temp_get .20.3[dCJ 
J 
r~ 
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a a ~ ;; 12 
;; Jj-<~~~'A ~ IL-..f \ 
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r'r'r-:r-: It'ilt''ilt'ilt'ilt'i ~..j 't~.t"'it"'i~~t"'i t"'i NN";";"':"":"';":": ...;-:..: 0 0 
tL.__ x: pans per MUllon : IH 
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r-:r--:~r--: wilf'illilt'ilfivi 
'-PBB-1998 06.13.55 
'-PZB-1998 03. U .3. 
• Eclip•• 270 
• DELT"-.NMR 
• DJMl-3S-Fl-3_PROTON.2 
· 
• DJMl-3S-Fl-3 
dEDL~? 
Spec sit. 
Spec Typ. 
Fil. Name 
Author 
Sample ID 
Content 
Creation Dat. 
R.vi.ion Dat. 
Data Format • 1D COMPLEX 
Dimsn.ion. • X 
D~ Title • lH 
Dim Size • 1638. 
Dim Unit. • [ppm] 
Scan. • 16 
X_domain • lH 
X_off••t • 5.0[ppm] 
X_fr.q • 270.167'3928[MHz] 
x_....p • '.OS350621[kRz] 
Pield_.trangth • 6.3'S"5[T] 
Recvr_gain • 16 
Solvent • CRLOROPORM-D 
Spin_g. t • 15[Hz] 
Temp_g.t • 20.6[dC] 
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X : parts per Million: ] H 
File C:\HPCHEM\1\DATA\DJMl-39.D 
Operator dustin mergott 
Acquired 11 Feb 98 2:38 pm using AcqMethod DUSTIN 
Instrument GC/MS Ins 
Sample Name: 
Misc Info 
Vial Number: 1 
f\bundance TIC: OJM1-39.0 
260000 
240000 
220000, 
200000 
180000 
160000 
140000 
120000 
100000 \ 
80000
 
60000 1
 
40000
 
20000
 Jv
--... 1. .... .;­
! 0 L~~Tl--.-r-r---,----,~..-r~,...,...~,___,___.__=;:::::;::::;=;::::;::::;::::;:::::;::;::::;:::~::;::;:::::;::::;:::;::::;:::::;=;:=;:.:;::::;::::;=~=;:=;::::;::::;:::::~~:::;::::;::;=;:= 
!Time-> 4.00 5.00 6.00 7.00 8.00 9.00 10.00 11 ~Oo 12.00 13.00 14.00 
Abundance Scan 39 (3.789 min): 39.0 
I 2145 pee..~ l.v't' ~ ~'\'\ 
35000I 
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.1 III II Iii11111 ~o " III oL ,lidl I ~I~I' 1,1.11, 
10 . 2b
'r!J/z-> 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190' 200 210 220 230 240 
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219 
III,I141 155 I, ,II I.1 I. 
File C:\HPCHEM\1\DATA\DJMl-39.D 
Operator dustin mergott 
Acquired 11 Feb 98 2:38 pm using AeqMethod DUSTIN 
Instrument GC/MS Ins 
Sample Name: 
Misc· Info 
Vial Number: 1 
bundance TIC: OJM1-39.0 
2600001 $ 
, 240000j ~o ....... p-oc. ...J 
,., I 
220000J i6t­ "'~J 
200000 
m . W. = 3 12..2.. ,j/""ClJ 
180000 
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. \ 
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60000 r:1 
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I e,~ V, 
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O1, ~-r-r-.,...,-r---""",,--'-'--,-,---'-'------r::=::;:::;::::;:::;::::;:::;::::~~~~:::::;::::;:::::;=:;::::;=:;:::::;::::;::::::;::::;:::::;:::;:::::r=;=:~:;:::;=:;:::::;=:;::,=:~ 'i' I' 'I' 'I' ii' I"" I" 'I " 'I' 'I' 'I 
rrime--> 4.00 5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 
~bundance Scan 146 (5.899 min): 39.0 
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File C:\HPCHEM\1\DATA\DJMl-47.D 
Operator ofv 
Acquired 25 Feb 98 4:40 pm using AeqMethod DUSTIN 
Instrument GC/MS Ins 
Sample Name: 
Mise Info 
Vial Number: 1 
bundance TIC: DJM1-47.D 
1'6"07~ 
\ 
1.4e+07 \ 
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, J 
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I 0 L..-..,.-..--'-I~,---,-,,....,-.,'I~''''-~''----,-, ::;==;=;=-=rl=r,=;-FT,"1'1=;=;=;:=,:;::,'1=';=;==;='"=1'-'-'-,-,-,-,-"'-'1~,-r,-",....,...,TI"-,,,...-,-,.....,,-,.-'~~"'::::;::;-""--':::;::~I 00::;:::;,;:::;::,=r=;;= 
fTime-> 3.00 4.00 5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 
---_.._--------~;--~"""~~~~~-----------------,Scan 43 (2.870 min): 47.0
-b~58n5Bi 
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, 124 27 39 I 65 
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! I 
File C:\HPCHEM\1\DATA\DJMl-37.D 
Operator dustin mergott 
Acquired 11 Feb 98 3:58 pm using AcqMethod DUSTIN 
Instrument GC/MS Ins 
Sample Name: 
Misc Info 
Vial Number: 1 
Abundance TIC: OJM1-37.0 
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.s 
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Abundance Scan 39 (3.789 min): 37.0 
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File C:\HPCHEM\1\DATA\DJMl-37.D 
Operator dustin mergott 
Acquired 11 Feb 98 3:58 pm using AeqMethod DUSTIN 
Instrument GC/MS Ins 
Sample Name: 
Mise Info 
Vial' Number: 1 
r"i TIC: OJM1-37.0 s 
" 
~bundance Scan 350 (9.921 min): 37.0 
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File C:\HPCHEM\1\DATA\DJMl-41.D 
Operator Dustin Mergott 
Acquired 16 Feb 98 11:47 am using AcqMethod DUSTIN 
Instrument GC/MS Ins 
Sample Name: 
Misc Info 
Vial Number: 1 
~bundance 
2.M7~\ 
2.2e+07 
TIC: OJM1-41.0 
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File C:\HPCHEM\1\DATA\DJMl-43.D 
Operator Dustin Mergott 
Acquired 16 Feb 98 12:29 pm using AcqMethod DUSTIN 
Instrument GC/MS Ins 
Sample Name: 
Misc Info 
Vial Number: 1 
~bundance TIC: OJM1-43.0 
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File C:\HPCHEM\1\DATA\DJMl-45.D 
Operator Dustin Mergott 
Acquired 17 Feb 98 11:53 am using AcqMethod DUSTIN 
Instrument GC/MS Ins 
Sample Name: 
Misc Info 
Vial Number: 1 
Abunda-n-ce------- - • - ---- -- ------:;;TI;-;;C,.-::;::"OJ7.M7.1;--4~5;-;.O:O-----------------
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Abundance Scan 38 (2.770 min): 45.0 
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dEDL&t? 
CO! 
~ 
• Eclipse 270 
• DELTA_NMR 
• DJMl-51_PROTON.2
-
- DJMl-51 
· ll-MAR-1998 03:01:30 
ll-MAR-1998 00,02:21 
- 8 
- CRLOROFORM-D 
- 16 [Hz) 
- 20.7[dC) 
Spec Site 
Spec Type 
Data Format • 10 COMPLBX 
Dimensions • X 
Dim Title • lK 
Dim Size - 16384 
Dim Units - [ppm) 
Scans - 16 
X_domain - 1ft 
X_offset - 5.0[ppm) 
X_freq - 270.16743928[MHz) 
X_sweep - 4.05350628[kHz) 
Field_strength. 6.345446[T) 
Recvr_gain 
solvent 
Spinj1et 
Temp_get 
File NlUII8 
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Sample ID 
Content 
Creation Date 
Revision Date 
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File N...... DJMl-53_PROTON.2~ 
o Author 
N SUlPle ID · • DJKl-53 
Content 
Creation Date l1-KAR-l99S 01.&9.2S 
Revi.ion Dat. 10-KAR-199S 22.50:09 
Spec Sit. Eclip•• 270 
Spec Type DELTA_NMR 
Data Format 1D COMPLEX 
Dimen.ion. 
• XDim Title 
• 1H 
Dim Size • 1638& 
Dim Unit. • [ppm) 
• 16 
x_domain 
• 1H 
X_off.et • 5.0[ppm)
X_frell • 270.167&392S[KHz) 
x_.....p • &.0535062S[kHz) 
Piel"'-.atr.nllth • 6.H5U6[T) 
Recvr_llain 
• 9SolV'11!1t • CHLOROPORM-D 
Spin_g.t • 16[Hz) 
TIIIIIP~·t • 20.6[dc) 
o 
o
~ ~ 
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r-=r-:r-: r' ~ W"i~lI"i ..: "If• ...:..: • l""iroil""irr',I""iMr"iI""iC"'i ...;..;...:~...;...;...;...;...;...;....;...;...; 0 0 
X: pans per Million: IH 
File C:\HPCHEM\1\DATA\DJMl-55.D 
Operator Dustin Mergott 
Acquired 12 Mar 98 4:43 pm using AeqMethod DUSTIN 
Instrument GCjMS Ins 
Sample Name: 
Mise Info 
Vial Number: 1 
TIC: DJM1-55.D ~bundance ~ 
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File C:\HPCHEM\1\DATA\DJMl-57.D 
Operator Dustin Mergott 
Acquired 12 Mar 98 5:04 pm using AcqMethod DUSTIN 
Instrument GC/MS Ins 
Sample Name: 
Misc Info 
Vial Number: 1 
~bundance TIC: OJM1-57.0 
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